About: KannaLife

An Entity of Type: agent, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Kannalife Sciences Inc. , a subsidiary of Neuropathix, Inc., is a bio-pharmaceutical and phyto-medical company based in Doylestown, Pennsylvania founded by Dean Petkanas and Thoma Kikis. Kannalife was formed in 2010 and is involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. Kannalife was featured in Sports Illustrated article on using cannabinoids to treat Concussions and CTE.

Property Value
dbo:abstract
  • Kannalife Sciences Inc. , a subsidiary of Neuropathix, Inc., is a bio-pharmaceutical and phyto-medical company based in Doylestown, Pennsylvania founded by Dean Petkanas and Thoma Kikis. Kannalife was formed in 2010 and is involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. In 2011, the company was granted an Exclusive License by National Institutes of Health – Office of Technology Transfer (NIH-OTT) for the Commercialization of patent US 6630507, “Cannabinoids as Antioxidants and Neuroprotectants." Kannalife is currently conducting research and development at the Pennsylvania Biotechnology Center of Bucks County in Doylestown, PA, for a target drug candidate, KLS-13019 to treat Chemotherapy-induced peripheral neuropathy, Hepatic encephalopathy, Mild Traumatic Brain Injury and CTE, an oxidative stress related disease that affects the cognitive and behavioral functions, and the wellness of the brain. Kannalife was featured in Sports Illustrated article on using cannabinoids to treat Concussions and CTE. (en)
dbo:foundedBy
dbo:foundingYear
  • 2010-01-01 (xsd:gYear)
dbo:industry
dbo:location
dbo:thumbnail
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 40215057 (xsd:integer)
dbo:wikiPageLength
  • 5362 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1113571932 (xsd:integer)
dbo:wikiPageWikiLink
dbp:assets
  • Exclusive License of patent (en)
dbp:foundation
  • 2010 (xsd:integer)
dbp:founders
  • Dean Petkanas, Thoma Kikis (en)
dbp:homepage
dbp:industry
dbp:location
dbp:logo
  • 250 (xsd:integer)
dbp:name
  • Kannalife Sciences Inc. (en)
dbp:type
  • Private (en)
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • Kannalife Sciences Inc. , a subsidiary of Neuropathix, Inc., is a bio-pharmaceutical and phyto-medical company based in Doylestown, Pennsylvania founded by Dean Petkanas and Thoma Kikis. Kannalife was formed in 2010 and is involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. Kannalife was featured in Sports Illustrated article on using cannabinoids to treat Concussions and CTE. (en)
rdfs:label
  • KannaLife (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Kannalife Sciences Inc. (en)
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License